PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,312,743 | +131.2% | 178,952 | +1.4% | 0.00% | 0.0% |
| Q4 2022 | $1,865,224 | +151.0% | 176,464 | +6.9% | 0.00% | – |
| Q3 2022 | $743,000 | +28.8% | 165,106 | +14.7% | 0.00% | – |
| Q2 2022 | $577,000 | -46.1% | 144,008 | -1.4% | 0.00% | – |
| Q1 2022 | $1,070,000 | +32.6% | 146,063 | +1.8% | 0.00% | – |
| Q4 2021 | $807,000 | -8.9% | 143,526 | +3.7% | 0.00% | – |
| Q3 2021 | $886,000 | -72.0% | 138,358 | -63.1% | 0.00% | -100.0% |
| Q2 2021 | $3,161,000 | -17.3% | 374,954 | +3.0% | 0.00% | 0.0% |
| Q1 2021 | $3,821,000 | -28.8% | 364,029 | +14.9% | 0.00% | -50.0% |
| Q4 2020 | $5,367,000 | +33.0% | 316,796 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $4,036,000 | +179.7% | 314,540 | +207.7% | 0.00% | +100.0% |
| Q2 2020 | $1,443,000 | +976.9% | 102,220 | +602.4% | 0.00% | – |
| Q1 2020 | $134,000 | -38.2% | 14,553 | 0.0% | 0.00% | – |
| Q4 2019 | $217,000 | – | 14,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |